Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PURVA.NS Stock Summary
Top 10 Correlated ETFs
PURVA.NS
In the News
PURVA.NS Financial details
Company Rating
Neutral
Market Cap
51.06B
Income
755.1M
Revenue
16.54B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
672
Optionable
No
Shortable
Yes
Earnings
24 May 2024
P/E
276.79
Forward P/E
25.9
PEG
-56.82
P/S
3.32
P/B
2.84
P/C
-
P/FCF
-
Quick Ratio
0.16
Current Ratio
1.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.19
EPS next Y
8.1
EPS next Q
-
EPS this Y
-54.98%
EPS next Y
153.92%
EPS next 5Y
226.02%
EPS last 5Y
-10.29%
Revenue last 5Y
-9.51%
Revenue Q/Q
55.76%
EPS Q/Q
-800%
-
-
-
-
SMA20
-18.66%
SMA50
-10.24%
SMA100
41.19%
Inst Own
-
Inst Trans
-
ROA
-
ROE
2%
ROC
0.15%
Gross Margin
61%
Oper. Margin
26%
Profit Margin
1%
Payout
-
Shs Outstand
237.15M
Shs Float
22.83M
-
-
-
-
Target Price
-
52W Range
58.2-268.95
52W High
-21.74%
52W Low
+261.64%
RSI
46.54
Rel Volume
0.29
Avg Volume
988.19K
Volume
287.32K
Perf Week
8.74%
Perf Month
-7.54%
Perf Quarter
64.25%
Perf Half Y
87.19%
-
-
-
-
Beta
0.594
-
-
Volatility
11.1%, 23.23%
Prev Close
-2.8%
Price
209.75
Change
-0.55%
PURVA.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 85.84 | 88.93 | 39.86 | 38.75 | 52.11 | |
Net income per share | 4.82 | 3.72 | -0.2 | 6.22 | 2.8 | |
Operating cash flow per share | -5.52 | 24.37 | 10.46 | 5.64 | 6.12 | |
Free cash flow per share | -6.73 | 23.44 | 10.29 | 5.23 | 4.77 | |
Cash per share | 6.29 | 4.5 | 7.42 | 13.02 | 22.67 | |
Book value per share | 78.28 | 80.69 | 81.69 | 86.11 | 83.78 | |
Tangible book value per share | 77.82 | 80.22 | 81.26 | 85.86 | 83.55 | |
Share holders equity per share | 78.28 | 80.69 | 81.69 | 86.11 | 83.78 | |
Interest debt per share | 135.73 | 127.65 | 136.62 | 124.72 | 139.29 | |
Market cap | 17.61B | 8.39B | 16.35B | 25.3B | 15.5B | |
Enterprise value | 45.07B | 34.27B | 43.1B | 48.82B | 41.48B | |
P/E ratio | 15.4 | 9.49 | -350.04 | 17.14 | 23.31 | |
Price to sales ratio | 0.86 | 0.4 | 1.76 | 2.75 | 1.25 | |
POCF ratio | -13.45 | 1.45 | 6.69 | 18.93 | 10.67 | |
PFCF ratio | -11.03 | 1.51 | 6.8 | 20.38 | 13.71 | |
P/B Ratio | 0.95 | 0.44 | 0.86 | 1.24 | 0.78 | |
PTB ratio | 0.95 | 0.44 | 0.86 | 1.24 | 0.78 | |
EV to sales | 2.21 | 1.62 | 4.63 | 5.31 | 3.36 | |
Enterprise value over EBITDA | 8.91 | 6.97 | 11.54 | 18.25 | 9.6 | |
EV to operating cash flow | -34.43 | 5.93 | 17.64 | 36.53 | 28.57 | |
EV to free cash flow | -28.24 | 6.16 | 17.93 | 39.33 | 36.7 | |
Earnings yield | 0.06 | 0.11 | 0 | 0.06 | 0.04 | |
Free cash flow yield | -0.09 | 0.66 | 0.15 | 0.05 | 0.07 | |
Debt to equity | 1.56 | 1.41 | 1.49 | 1.29 | 1.48 | |
Debt to assets | 0.33 | 0.33 | 0.34 | 0.3 | 0.29 | |
Net debt to EBITDA | 5.43 | 5.27 | 7.17 | 8.79 | 6.01 | |
Current ratio | 1.18 | 1.17 | 1.24 | 1.3 | 1.19 | |
Interest coverage | 1.39 | 1.3 | 0.79 | 0.71 | 0.81 | |
Income quality | -0.76 | 4.12 | -84.53 | 0.47 | 2.62 | |
Dividend Yield | 0.03 | 0.03 | 0 | 0 | 0.08 | |
Payout ratio | 0.41 | 0.31 | 0 | 0 | 1.78 | |
Sales general and administrative to revenue | 0.03 | 0.02 | 0.06 | 0.08 | 0.15 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.22 | -0.04 | -0.02 | -0.07 | -0.22 | |
Capex to revenue | -0.01 | -0.01 | 0 | -0.01 | -0.03 | |
Capex to depreciation | -1.91 | -0.97 | -0.2 | -0.54 | -1.88 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 92.14 | 82.23 | 19.17 | 109.81 | 72.69 | |
ROIC | 0.06 | 0.06 | 0.1 | 0.03 | 0.07 | |
Return on tangible assets | 0.01 | 0.01 | 0 | 0.02 | 0.01 | |
Graham Net | -118.71 | -100.94 | -121.24 | -108.35 | -139.73 | |
Working capital | 11.62B | 10.18B | 14.46B | 17.6B | 14.47B | |
Tangible asset value | 18.46B | 19.03B | 18.98B | 20.36B | 19.81B | |
Net current asset value | 6.94B | 8.26B | 8.48B | 11.39B | 9.56B | |
Invested capital | 1.56 | 1.41 | 1.49 | 1.29 | 1.48 | |
Average receivables | 3.52B | 7.63B | 6.27B | 4.08B | 4.57B | |
Average payables | 4.54B | 5.03B | 5.47B | 4.96B | 4.63B | |
Average inventory | 57.27B | 64.29B | 62.5B | 66.13B | 72.21B | |
Days sales outstanding | 126.35 | 142.17 | 169.93 | 151.88 | 157.16 | |
Days payables outstanding | 140.24 | 152.53 | 517.12 | 469.61 | 389.32 | |
Days of inventory on hand | 2.03K | 1.73K | 5.95K | 7.37K | 6.04K | |
Receivables turnover | 2.89 | 2.57 | 2.15 | 2.4 | 2.32 | |
Payables turnover | 2.6 | 2.39 | 0.71 | 0.78 | 0.94 | |
Inventory turnover | 0.18 | 0.21 | 0.06 | 0.05 | 0.06 | |
ROE | 0.06 | 0.05 | 0 | 0.07 | 0.03 | |
Capex per share | -1.21 | -0.93 | -0.17 | -0.4 | -1.36 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 16.55 | 16.4 | 13.63 | 15.53 | 24.22 | |
Net income per share | 0.95 | 1.12 | -0.75 | -0.47 | 3.29 | |
Operating cash flow per share | 0.44 | 0.32 | 6.13 | 6.15 | 0.57 | |
Free cash flow per share | 0.44 | 0.32 | 6.13 | 4.67 | 0.57 | |
Cash per share | 14.31 | 22.67 | 15.07 | 32.47 | 0 | |
Book value per share | 81.97 | 83.78 | 84.06 | 82.57 | 0 | |
Tangible book value per share | 0 | 83.55 | 0 | 82.39 | 0 | |
Share holders equity per share | 81.97 | 83.78 | 84.06 | 82.57 | 0 | |
Interest debt per share | 3.96 | 128.43 | 4.14 | 133.7 | 4.44 | |
Market cap | 21.78B | 15.5B | 21.9B | 31.16B | 44.38B | |
Enterprise value | 25.18B | 41.48B | 25.47B | 55.92B | 44.38B | |
P/E ratio | 24.17 | 14.53 | -30.64 | -69.56 | 14.24 | |
Price to sales ratio | 5.55 | 3.98 | 6.77 | 8.46 | 7.74 | |
POCF ratio | 209.85 | 203.38 | 15.07 | 21.36 | 329.74 | |
PFCF ratio | 209.85 | 203.38 | 15.07 | 28.14 | 329.74 | |
P/B Ratio | 1.12 | 0.78 | 1.1 | 1.59 | 0 | |
PTB ratio | 1.12 | 0.78 | 1.1 | 1.59 | 0 | |
EV to sales | 6.42 | 10.66 | 7.88 | 15.18 | 7.74 | |
Enterprise value over EBITDA | 19.7 | 38.7 | 33.77 | 56.99 | 20.35 | |
EV to operating cash flow | 242.54 | 544.41 | 17.53 | 38.33 | 329.74 | |
EV to free cash flow | 242.54 | 544.41 | 17.53 | 50.5 | 329.74 | |
Earnings yield | 0.01 | 0.02 | -0.01 | 0 | 0.02 | |
Free cash flow yield | 0 | 0 | 0.07 | 0.04 | 0 | |
Debt to equity | 0 | 1.48 | 0 | 1.57 | 0 | |
Debt to assets | 0 | 0.29 | 0 | 0.28 | 0 | |
Net debt to EBITDA | 2.66 | 24.24 | 4.74 | 25.24 | 0 | |
Current ratio | 0 | 1.19 | 0 | 1.16 | 0 | |
Interest coverage | 1.31 | 1.01 | 0.6 | 0.88 | 2.01 | |
Income quality | 0.46 | 0.29 | -8.13 | -13.03 | 0.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.16 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | -0.24 | 0 | |
Capex to revenue | 0 | 0 | 0 | -0.1 | 0 | |
Capex to depreciation | 0 | 0 | 0 | -5.43 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 41.86 | 46.03 | 37.75 | 29.62 | 0 | |
ROIC | 0.05 | 0.46 | 0.02 | 0.02 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 14.31 | -139.73 | 15.07 | -161.4 | 0 | |
Working capital | 3.39B | 14.47B | 3.57B | 13.72B | 0 | |
Tangible asset value | 0 | 19.81B | 0 | 19.54B | 0 | |
Net current asset value | 3.39B | 9.56B | 3.57B | 7.53B | 0 | |
Invested capital | 0 | 1.48 | 0 | 1.57 | 0 | |
Average receivables | 2.25B | 2.66B | 2.66B | 2.86B | 2.86B | |
Average payables | 2.61B | 2.46B | 2.46B | 2.63B | 2.63B | |
Average inventory | 35.93B | 38.11B | 38.11B | 40.9B | 40.9B | |
Days sales outstanding | 0 | 123.11 | 0 | 139.56 | 0 | |
Days payables outstanding | 0 | 221.43 | 0 | 423.34 | 0 | |
Days of inventory on hand | 0 | 3.44K | 0 | 6.58K | 0 | |
Receivables turnover | 0 | 0.73 | 0 | 0.64 | 0 | |
Payables turnover | 0 | 0.41 | 0 | 0.21 | 0 | |
Inventory turnover | 0 | 0.03 | 0 | 0.01 | 0 | |
ROE | 0.01 | 0.01 | -0.01 | -0.01 | 0 | |
Capex per share | 0 | 0 | 0 | -1.48 | 0 |
PURVA.NS Frequently Asked Questions
What is Puravankara Limited stock symbol ?
Puravankara Limited is a IN stock and trading under the symbol PURVA.NS
What is Puravankara Limited stock quote today ?
Puravankara Limited stock price is $209.75 today.
Is Puravankara Limited stock public?
Yes, Puravankara Limited is a publicly traded company.